The International Classification of Diseases 11 (ICD 11) has come into effect on 1 January 2022. Among major changes in this new classifications, stroke has been moved from circulatory system diseases back to neurological disorders. The ICD is maintained by WHO and distributed in countries across the globe. An ICD read more

The care of patients with neurological disorders is not complete until the patient’s functional ability in all aspects of life has been addressed. Promoting FUNCTION is the major goal of rehabilitation. This includes optimal functioning in the home, community, at work and in social settings. These important aspects of life are read more

The complexity of the brain has long hindered attempts to fully understand it— knowledge that is fundamental in the search for cures for brain disorders. These challenges are reflected by the continuously growing burden brain disorders impose on health care systems, economies and, most importantly, the people affected by them, read more

Neurology is one of the main medical specialities. Neurological disorders, of which there are over 400, exert a huge burden on our societies. Yet, until recently, neurological disorders have not been identified as a distinct disease group with overarching characteristics, similar to the collective approach taken to diseases like cancers. read more

The two most common neurological disorders, stroke and dementia are preventable to different degrees and most others can be made less likely or less severe through the promotion of brain health. Neurological disorders have become the leading cause of disability adjusted life years (DALY’s) a joint measure of premature death read more

Prof Valery Feigin, Global Policy Committee, World Stroke Organization highlights the importance of action on stroke prevention to secure health for all. Stroke is the major contributor to deaths from neurological disorders globally. Based on current data 1 in 4 individuals over the age of 25 will have a stroke read more

There is unequal access to disease-modifying therapies for multiple sclerosis. Cost and affordability can be major drivers for narrowing health inequities for people within and between countries. Improving access to treatment requires for-profit and non-profit organisations to have more open conversations to create fairer societies. Equity is a moral principle, read more